The first stage of the pancreatic cancer diagnosis is tumor detection. The tumor is not easily detectable and hence the increased mortality rate of the disease. The detection of the tumor is therefore an important stage in the efforts of treating and curing pancreatic cancer. MRI (Magnetic Resonance Imaging) is a process that enables the early confirmation of the pancreatic tumor thereby increasing the curability of the disease. Contrast agents are used in the MRI process. The commonly used contrast images are Gadolinium based
Contrast agents and Iron Oxide nanoparticle enhanced contrast agents. The contrast agents allow for the formation of distinct images subsequently allowing for better determination of Carcinoma cells. The research paper looks into the role that Iron Oxide Nanoparticles enhance the magnetic Resonance in the quest for pancreatic cancer diagnosis and treatment. The paper is broken down to the different MRI and its contrast agents, Nanotechnology, Iron Oxide nanoparticles, and their importance in the diagnosis and treatment of pancreatic cancer and finally the effectiveness and dependability of the Nanoparticles in the curability of pancreatic cancer. The paper has clearly cut objectives, which should be addressed comprehensively throughout the paper.
According to Zhou and Lu (2012), Magnetic Resonance Imaging is a powerful medical modality that displays the anatomical structures of the body. MRI is quite important in detecting and characterizing the diseased tissues in the body as well as solid tumors. MRI produces a three-dimension, high resolution and contrast images of the tissues or tumor and does not release ionization radiation in the process. MRI uses a variety of contrast agents in relation to the tissue or body part involved in the process. Over the years, since its inception three years ago, the